Joshua A Sonnen Selected Research

Biomarkers (Surrogate Marker)

1/2022	18F-MK-6240 tau-PET in genetic frontotemporal dementia.
12/2021	Theoretical impact of the AT(N) framework on dementia using a community autopsy sample.
10/2011	Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.
1/2010	Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia.
8/2008	Biomarkers for cognitive impairment and dementia in elderly people.
8/2007	Biomarkers for Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joshua A Sonnen Research Topics

Disease

14	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2007
13	Dementia (Dementias) 01/2022 - 08/2007
6	Cognitive Dysfunction 01/2022 - 08/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 07/2009
4	Disease Progression 01/2023 - 08/2008
2	Tauopathies 01/2022 - 12/2021
2	Infarction (Infarctions) 05/2014 - 03/2009
2	Hypertension (High Blood Pressure) 07/2012 - 11/2009
1	Gliosis 01/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023
1	Stroke (Strokes) 01/2022
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Endotoxemia 01/2018
1	Glioma (Gliomas) 01/2018
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2017
1	Amyloid Plaque 10/2017
1	Cerebrovascular Trauma 09/2011
1	Hippocampal Sclerosis 05/2011
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 05/2011
1	Seizures (Absence Seizure) 05/2011
1	Crush Injuries 02/2010
1	Nervous System Trauma 02/2010
1	Brain Injuries (Brain Injury) 02/2009
1	Prodromal Symptoms 08/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2007
6	Amyloid (Amyloid Fibrils)IBA 12/2021 - 07/2009
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 11/2009
3	Free RadicalsIBA 09/2011 - 08/2008
2	LipidsIBA 09/2019 - 01/2019
2	Amyloid beta-PeptidesIBA 01/2018 - 03/2009
2	Apolipoproteins E (ApoE)IBA 11/2014 - 10/2007
2	AntioxidantsIBA 02/2009 - 08/2008
1	PrionsIBA 01/2023
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	flutemetamolIBA 01/2018
1	CytokinesIBA 01/2018
1	Threonine (L-Threonine)FDA Link 02/2015
1	Alanine (L-Alanine)FDA Link 02/2015
1	anordiol (AF 45)IBA 05/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2011
1	DNA (Deoxyribonucleic Acid)IBA 05/2011
1	ApolipoproteinsIBA 05/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2010
1	AutoantigensIBA 02/2010
1	Glatiramer Acetate (Copaxone)FDA Link 02/2010
1	Protein AggregatesIBA 07/2009
1	Detergents (Detergent)IBA 07/2009
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2009
1	Interleukin-6 (Interleukin 6)IBA 03/2009

Therapy/Procedure

7	Therapeutics 01/2023 - 08/2007
1	Lasers (Laser) 01/2022
1	Secondary Prevention 12/2021